Long-term updates of original prospective clinical trials have confirmed th
at breast conservation treatment is the appropriate primary therapy for mos
t women with stage I and II breast cancer. The procedure probably is underu
sed in many areas of North America still. The discomfort of many surgeons i
n recommending breast-conserving surgery may relate to a misunderstanding o
f the difference between risks of local recurrence and distant treatment fa
ilure.